Introduction {#s1}
============

Temporal lobe epilepsy (TLE) is associated with marked psychiatric comorbidity.[@R1] [@R2] Affective disorders (depression/anxiety) are the most common interictal psychopathologies,[@R3] leading to a decreased quality of life[@R4] and an increased risk of suicide.[@R2] [@R5]

Historically, affective disorders in epilepsy have been conceptualised as a complication of the underlying seizure disorder.[@R6] Recent epidemiological studies however suggest a more complex relationship, as a history of major depression[@R7] or anxiety disorders[@R10] [@R11] is associated with an increased risk of developing epilepsy. Moreover, a lifetime history of affective psychopathology has been associated with a poorer response to antiepileptic medication[@R12] and epilepsy surgery.[@R13]

The primary affective disorder literature suggests that dysfunction within an extended network including the medial prefrontal cortex (mPFC) and anatomically-related limbic, striatal, thalamic and basal forebrain structures is pathogenic in the onset and maintenance of affective morbidity.[@R17] [@R18] In parallel, evidence from structural[@R19] and functional neuroimaging[@R28] suggests the same structures may be involved in the development and maintenance of affective symptoms in TLE.

More recently, functional imaging studies have focused on the default mode network (DMN),[@R38] [@R39] a resting-state network that putatively mediates task-independent, self-referential cognition and interactive modulation between intrinsic activities and external tasks.[@R40] DMN dysfunction has been implicated in psychiatric diagnoses.[@R41] [@R42] Studies of primary unipolar and bipolar depression have reported reduced deactivation of the DMN during self-referential,[@R43] emotional processing[@R44] [@R45] and verbal working memory (WM) tasks[@R46] with altered patterns of functional connectivity at rest relative to healthy brains.[@R47] [@R48] DMN dysfunction has also been demonstrated in anxiety disorders (see[@R49] for review).

Studies of the DMN in TLE have indicated reduced functional connectivity[@R50] [@R51] and altered task-related deactivations compared with healthy controls.[@R52] [@R53] Emerging evidence suggests that DMN connectivity may be further complicated by comorbid psychopathology.[@R54] Chen *et al*[@R54] demonstrated that in depressed mTLE patients, functional connectivity among the anterior prefrontal cortex, limbic system and temporal lobe is significantly reduced compared with non-depressed TLE patients and healthy controls. However, it is still unknown whether comorbid affective morbidity in TLE modulates the *behaviour* of this neural network.

WM tasks are normally associated with deactivation of the DMN.[@R57] The aim of this study was to examine DMN function and structure in patients with TLE and a history of comorbid affective disorders. Specifically, we hypothesised that patients with a lifetime affective diagnosis would demonstrate reduced deactivation of the DMN during a WM task, similar to patients with primary affective disorders,[@R40] and this would be associated with poorer performance.

Materials and methods {#s2}
=====================

Subjects {#s2a}
--------

A total of 48 right-handed patients with medically refractory TLE undergoing presurgical evaluation at the National Hospital for Neurology and Neurosurgery participated in this study between 2009 and 2012. Seventeen patients had at least one lifetime episode of an affective disorder (psychiatric history (PHx) group). Thirty-one patients had no history of psychiatric disorder (none-psychiatric history (nPHx) group). We also recruited 30 native English speaking healthy volunteers (HVs) without any history of neurological or psychiatric disease. Clinical and demographic data are detailed in [table 1](#JNNP2013306966TB1){ref-type="table"}.

###### 

Demographic and clinical characteristics for patients and healthy volunteers (HVs)

                                  PHx (n=17)     nPHx (n=31)      HV (n=30)      p Value
  ------------------------------- -------------- ---------------- -------------- ---------
  Age, years\*                    40 (17--53)    38 (19--55)      37 (19--64)    0.74
  Female                          14 (82%)       17 (55%)         18 (60%)       0.20
  Lesion laterality (R/L)         7/6 (41/35%)   11/16 (35/52%)   NA             0.44
  Epilepsy onset, years†          14 (7.5--25)   17 (11--22)      NA             0.94
  Epilepsy duration, years†       21 (10--30)    19 (10--30)      NA             0.70
  MRI negative                    4 (23%)        4 (13%)          NA             0.43
  HS                              7 (41%)        20 (64%)         NA             0.12
  Cavernomas                      2 (12%)        2 (6.5%)         NA             0.61
  DNET                            2 (12%)        5 (16%)          NA             1.00
  FCD                             0 (0%)         2 (6.5%)         NA             0.53
  Other‡                          2 (12%)        3 (10%)          NA             1.00
  Dual pathology                  0 (0%)         5 (16%)          NA             0.15
  Number of AEDs\*                3 (1--4)       2 (1--4)         NA             0.28
  Premorbid IQ§                   99.5 (17)      97.4 (12.3)      111 (10.6)¶    
  BDI-FS\*                        4 (0--12)      2 (0--9)         0.5 (0--5)¶    
  BAI\*                           9 (2--33)      6 (0--28)        2.5 (0--12)¶   
  Lifetime psychiatric history:                                                  
   Unipolar depression            12 (70%)       NA               NA             
   Anxiety disorder               3 (18%)        NA               NA             
   Depression and anxiety         2 (12%)        NA               NA             

\*Median (range).

†Median (IQR).

‡Abnormal gyral folding/calcification or epidermoid cyst.

§Mean (SD).

¶Sig difference to both temporal lobe epilepsy groups (p\<0.01).

AEDs, antiepileptic drugs; DNET, dysembryoplastic neuroepithelial tumour; FCD, focal cortical dysplasia; HS, hippocampal sclerosis; NA, not applicable.

All patients had a structural MRI at 3 Tesla (3 T). Video-scalp EEG had confirmed seizure onset in the medial temporal lobe. All patients were taking antiepileptic medication, were native English speakers and had undergone a neuropsychological and neuropsychiatric evaluation as part of presurgical investigations. Seven of the 17 patients with a psychiatric history had a *current* psychiatric diagnosis (six unipolar depression; one anxiety disorder); 5 (29%) were prescribed antidepressant or anxiolytic medication.

The study was approved by the National Hospital for Neurology and Neurosurgery and the Institute of Neurology Joint Research Ethics Committee, and written informed consent was obtained from all subjects.

Neuropsychiatric evaluation and analysis {#s2b}
----------------------------------------

### Neuropsychiatric diagnosis: lifetime and current {#s2b1}

All patients were assessed by a neuropsychiatrist (JF) via a clinical interview. The diagnoses of mood and anxiety disorders fulfilled criteria according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Patients with affective symptoms related to antiepileptic (antiepileptic drug (AED)) therapy or the peri-ictal period (symptoms temporally related to seizure activity) were excluded from the study. We also excluded patients with a history of postictal or interictal psychosis.

### Beck Depression and Anxiety Inventories (BDI-FS and BAI) {#s2b2}

All subjects completed the Beck Depression Inventory-Fast Screen (BDI-FS[@R58]) and Beck Anxiety Inventory (BAI[@R59]). For both inventories, recommended severity ranges were employed (BDI-FS: 0--3 minimal; 4--6 mild; 7--9 moderate; 10--21 severe. BAI: 0--7 minimal; 8--15 mild; 16--25 moderate; 26--63 severe).

MR data acquisition {#s2c}
-------------------

MRI studies were performed on a 3 T General Electric Excite HDx scanner. Standard imaging gradients with a maximum strength of 40 m Tm^−1^ and slew rate 150 Tm^−1^s ^−1^ were used. All data were acquired using an eight-channel array head coil for reception and the body coil for transmission. Standard clinical sequences were performed and included a coronal T1-weighted volumetric acquisition with 170 contiguous 1.1 mm thick slices (matrix 256×256, inplane resolution 0.9375×0.9375 mm) used for voxel-based morphometry (VBM) analysis.

For the fMRI task, gradient-echo planar T2\*-weighted images were acquired, providing blood oxygenation level-dependent (BOLD) contrast. A total of 272 volumes were acquired over 1 run lasting 11 min 20 s. Each volume comprised 50 oblique axial 2.4 mm slices (with 0.1 mm gap) covering the whole brain, with a 24 cm field of view, SENSE factor 2, 64×64 matrix and an inplane resolution of 3.75×3.75 mm^3^. Echo time was 25 ms and repetition time was 2.5 s.

Diffusion tensor imaging acquisition {#s2d}
------------------------------------

Data were acquired using a cardiac-triggered single-shot spin-echo planar imaging sequence with echo time=73 ms. Sets of 60 contiguous 2.4 mm thick axial slices were obtained covering the whole brain, with diffusion sensitising gradients applied in each of 52 non-collinear directions (b value of 1200 mm^2^ s^−1^ (δ=21 ms, Δ=29 ms) using full gradient strength of 40 mT m^−1^) along with six non-diffusion-weighted scans. Gradient directions were calculated and ordered as described elsewhere.[@R60] Field of view was 24 cm, with matrix size of 96×96, zero filled to 128×128 during reconstruction, giving a reconstructed voxel size of 1.875×1.875×2.4 mm. The first four scans were discarded to ensure magnetisation equilibrium.

'Dot-back' fMRI paradigm and data analysis {#s2e}
------------------------------------------

A modified version of the 'n-back' task was used.[@R53] [@R61] Subjects were required to monitor the locations of dots (presentation time 440 ms; inter-stimulus interval 1500 ms) at a given delay from the original occurrence. There were three 30 s active conditions in total (0-, 1- and 2-back) presented to subjects five times in pseudorandom order, controlling for any order effect. Each block contained a maximum of 15 correct responses. Each active condition started with a 15 s resting baseline, with a further 15 s rest between active blocks during which the word 'rest' and all four dots were presented on screen, with the instruction to watch the screen. Subjects were required to move the joystick corresponding to the correct location of the current (0-back) or previously presented stimulus (1-back=previous presentation; 2-back=previous presentation but one; chance performance=25%). Percentages of correct 0, 1 and 2 dot-back trials were used in subsequent analysis as a measure of performance.

Data analysis {#s3}
=============

Imaging data were analysed with Statistical Parametric Mapping (SPM8) (<http://www.fil.ion.ucl.ac.uk>) using a two-level random-effects analysis. The imaging time series of each subject was realigned using the mean image as reference, spatially normalised into standard anatomical space (scanner-specific template) using the high-resolution whole brain-echo planar image and smoothed with a Gaussian kernel of 8 mm FWHM.

At the first level, trial-specific responses were modelled for each subject by convolving a δ function that indicated each block onset with the canonical haemodynamic response function (HRF) to create regressors of interest, one regressor for each block ('0-back', '1-back' and '2-back'). Each subject\'s movement parameters were included as confounds, and parameter estimates pertaining to the height of the HRF for each regressor of interest were calculated for each voxel. A single contrast image for the main effect of the DMN, modelling areas of increasingly negative blood-oxygen level-dependent (BOLD) signal change in response to increasing task demand,[@R62] was created for each subject. This contrast image was then used for the second-level analysis.

At the second level of the random-effects analysis, the subjects were divided into three groups: HV, nPHx and PHx. Analysis of covariance (ANCOVA) was performed with group as a factor to examine the main effects of the contrast and to highlight regions demonstrating more or less deactivation in one group compared with another. Gender, BDI-FS and BAI were included as regressors of no interest in all analyses. We report all activations at a threshold of p\<0.001, uncorrected for multiple comparisons. Post hoc analyses were performed to explore possible confounding factors associated with a significant main effect. No exams were discarded due to movement.

Post hoc imaging analyses {#s3a}
-------------------------

### Voxel-based morphometry {#s3a1}

The T1-weighted images were segmented into grey matter, white matter and cerebrospinal fluid using VBM8. Grey matter segmentations were normalised to MNI space and smoothed with a Gaussian kernel of 8 mm FWHM to produce maps of grey matter volume (GMV). An ANCOVA was performed to determine group differences in GMV.

Fractional anisotropy and structural connectivity analysis {#s3b}
----------------------------------------------------------

Diffusion tensor imaging data were preprocessed to remove motion artefact and eddy current distortion using the FSL eddycorrect routine. Maps of fractional anisotropy (FA) as an indicator of structural integrity were obtained using the FMRIB Diffusion Toolbox. They were non-linearly registered to the FMRIB58 template using FLIRT and FNIRT[@R63] and smoothed with a Gaussian kernel of 8 mm FWHM. A whole brain voxelwise ANCOVA of the FA maps between groups was undertaken in SPM8 with gender, BDI-FS and BAI scores included as regressors of no interest.

Tractography was performed in each subject to investigate the connectivity from the region identified by fMRI. A 6 mm sphere was defined in the white matter of the anterior corpus callosum underlying the activation maxima of the general linear model ANCOVA in the normalised space of the FMRIB58 template. This was transformed into each individual\'s native space using the inverse of transform calculated using FNIRT. Probabilistic tractography was then performed in native space from this seed using the FSL Diffusion Toolkit.[@R64] The connectivity maps generated for each subject were scaled by the number of streamlines initiated and normalised to the FMRIB58 template using the previously calculated transformation and smoothed with a Gaussian kernel of 8 mm FWHM. A whole brain voxelwise comparison of the structural connectivity maps between groups was undertaken in SPM8 with gender, BDI-FS and BAI scores included as regressors of no interest.

Results {#s4}
=======

Beck Depression and Anxiety Inventories {#s4a}
---------------------------------------

ANOVA revealed both TLE groups had significantly higher BDI-FS and BAI scores than controls on the day of scanning (p\<0.01). There were no significant differences between patient groups on these measures (see [table 1](#JNNP2013306966TB1){ref-type="table"}).

Inscanner performance {#s4b}
---------------------

ANOVA revealed a main effect of group on the 0-back (F (2, 75)=4.84, p\<0.05), 1-back (F (2, 75)=7.18, p\<0.05) and 2-back conditions (F (2, 75)=3.52, p\<0.05). Post hoc Bonferroni analysis showed the nPHx group performed significantly less well than HVs during the 0 dot-back condition (p=0.008). The PHx group also performed less well than HVs during the 0-back condition; however, this was not statistically significant. There was no significant difference between the patient groups during the 0-back condition. In the 1 dot-back condition, the PHx group performed significantly worse than the HVs (p\<0.001) and the nPHx group (p=0.049). In the 2 dot-back condition, the PHx group performed significantly less well than HVs (p=.029); however, their performance was not significantly different to the nPHx group (p=0.70). There was no significant difference between the HV and nPHx groups in either 1 or 2 dot-back conditions (see [figure 1](#JNNP2013306966F1){ref-type="fig"}).

![Group results across WM dot-back conditions (\*=p\<.05).](jnnp-2013-306966f01){#JNNP2013306966F1}

fMRI default mode network {#s4c}
-------------------------

Each group progressively deactivated the typical DMN consisting of the precuneus, medial frontal gyrus, anterior cingulate cortex (ACC), superior temporal gyri and hippocampi in response to increasing task demands ([figure 2](#JNNP2013306966F2){ref-type="fig"}). ANCOVA revealed the PHx group additionally deactivated the subgenual ACC (sACC) (x=2, y=28, z=−2) significantly more than the HV and the nPHx groups ([figure 3](#JNNP2013306966F3){ref-type="fig"}).

![Group results for progressive deactivation of the typical default mode network in response to increasing task demand (*p*\<.001, unc); controlling for both gender and current mood (BDI-FS and BAI scores). The superior temporal gyrus (STG) is not visualised owing to slice selection to show maximum default mode network deactivation.](jnnp-2013-306966f02){#JNNP2013306966F2}

![Additional deactivation of the [s]{.smallcaps}ACC (*x*=2, *y*=28, *z*=−2) in the PHx group only (p\<.001, unc); controlling for both gender and current mood (BDI-FS and BAI scores).](jnnp-2013-306966f03){#JNNP2013306966F3}

Post hoc fMRI analyses {#s4d}
----------------------

To determine whether the result for the PHx group may be influenced by current affective diagnosis, the data were reanalysed in a separate ANCOVA dividing the PHx group into lifetime (n=10) versus current (n=7) psychiatric diagnosis. There was no significant difference in the deactivation between these groups. Two further ANCOVAs were performed excluding those patients in the PHx group with scores falling in the moderate to severe range on the BDI-FS (n=3 removed) and BAI (n=4 removed). Both analyses revealed the same effect with significantly greater sACC deactivation (x=2, y=28, z=−2) in the PHx group compared with both the HV and nPHx groups.

A further ANCOVA was performed to explore the potential role of current psychiatric medication. The five patients taking antidepressant and anxiolytic medication were removed from the analysis. The same effect was observed in that the PHx group deactivated the same sACC cluster (x=2, y=30, z=−4) significantly more than HV and the nPHx groups.

Finally, to ensure the result was not driven by differences in task performance, correlational analyses were performed between the inscanner performance on each condition and the sACC BOLD parameter estimates for each subject. There was no significant linear correlation between performance and sACC signal in the 0, 1 or 2 dot-back conditions. There were no significant correlations between BDI-FS and BAI scores and sACC signal. In addition, as a manipulation check, all three groups progressively activated the expected fronto-parietal WM networks as a function of increasing WM demand.

Voxel-based morphometry {#s4e}
-----------------------

A whole brain VBM analysis was conducted to examine whether the main effect of group on DMN deactivation in the sACC was associated with structural differences in this region. There were no significant differences in GMV between the groups (all p  \>0.05).

FA maps {#s4f}
-------

To explore white matter integrity a whole brain voxelwise ANCOVA was performed using the FA maps generated at the individual level. There were no significant group differences in FA between the PHx group and HVs, or the nPHx group.

Structural connectivity {#s4g}
-----------------------

Seeding from the anterior corpus callosum, each group showed structural connectivity to the forceps minor bilaterally. ANCOVA revealed no significant group differences in the structural connectivity of this region.

Discussion {#s5}
==========

We report task-related DMN deactivation in patients with TLE and a diagnosed history of comorbid affective disorders. Contrary to our prediction, TLE patients with and without a history of affective disorders and HV demonstrated a progressive deactivation of the DMN in response to increasing WM task demands. Furthermore, the PHx group showed additional deactivation in the sACC, a mesolimbic structure implicated in the pathophysiology of primary depression.[@R65]

Increased deactivation within the DMN in the PHx group contrasts with the growing literature demonstrating that the DMN is less deactivated in affective disorders during self-referential,[@R23] emotional processing[@R24] [@R25] and verbal WM tasks.[@R26] Available evidence does indicate that DMN activity is significantly *attenuated* in TLE with seizures that impair awareness (see[@R68] for review).

EEG-fMRI studies have consistently demonstrated interictal epileptic discharges (IED)-related deactivations in the anterior[@R7] [@R69] and posterior[@R69] nodes of the DMN in TLE patients during rest. Laufs *et al*[@R69] suggested DMN deactivation in TLE is facilitated by the propagation of interictal epileptic activity to functionally interconnected default brain regions, resulting in secondary inhibition of non-seizing cortical regions via subcortical structures. We observed task-related deactivation in the PHx group that was significantly greater than that which occurred in the nPHx, and in a component of the 'affective network' (sACC),[@R40] supporting an additional, more specific, epilepsy--affective interaction. However, it is also possible that the rate of IEDs was dissimilar between the patient groups, particularly given the evidence that affective morbidity has been reported as predictive of seizure recurrence in *newly* treated patients[@R72] and has been associated with a poorer response to antiepileptic medication[@R12] and epilepsy surgery.[@R16] [@R73] As we did not collect simultaneous acquisition of EEG-fMRI data, we are unable to examine whether interictal epileptiform activity mediated the relation between sACC deactivation and/or cognitive performance in the PHx group.[@R76]

Our post hoc analyses indicated that the main effect of group on DMN deactivation of the sACC was not related to volumetric or structural connectivity differences of this region, but represents an isolated functional abnormality. Further studies using resting-state EEG-fMRI methodology are needed to explore this interactional physiological interpretation.

Functional neuroimaging techniques suggest that the ACC is functionally and structurally heterogeneous.[@R77] A meta-analyses of task-based studies demonstrated the functional heterogeneity separating the ACC into cognitive (dorsal) and affective (rostral) subdivisions.[@R77] In contrast to task-based approaches, Margulies *et al*[@R78] used resting-state functional connectivity to examine ACC functional segregation. They replicated a rostral/caudal ACC distinction, but also found a negative relationship (ie, anticorrelation) between the subgenual portions of the ACC and superior parietal regions, which are involved in higher order cognitive processes, such as attentional control and spatial WM.[@R79] Although the present study was not designed to disentangle task-related reciprocity between brain networks, we hypothesise that the observed additional sACC deactivation in the PHx group reflects the recruitment of *additional* neuronal resources (via anticorrelation) for successful task performance.

Within the larger context of the limbic-striato-pallidio-thalamic circuits implicated in the pathophysiology of primary depression, the functional implications of cortical-limbic circuits involving the medial prefrontal network merit comment in light of the abundant basic science literature available to guide translational models.[@R80] Specifically, the ACC receives extensive dopaminergic innervation from the ventral tegmental area (VTA) and sends projections to the VTA that regulate phasic dopamine (DA) release. In rats, stimulation of the mPFC areas elicits burst firing patterns in the VTA-DA neurons while inactivation of the mPFC converts burst firing patterns to pacemaker-like firing activity.[@R80] The burst firing patterns increase DA release in the nucleus accumbens, which is thought to encode information about reward prediction.[@R81] The mesio-limbic DA projections from the VTA to the nucleus accumbens and the mPFC thus play major roles in learning associations between operant behaviours or sensory stimuli and reward.[@R82] Further research is required to examine whether sACC dysfunction deleteriously affects the cortical drive on VTA-DA neuronal burst firing activity, which may impair reward learning in TLE patients with affective morbidity.

Previous research indicates that a lack of DMN deactivation, as found in association with psychiatric disturbance, is associated with impaired cognitive performance and deactivation in controls with performance gains.[@R57] As predicted, we observed poorer WM performance in the PHx group that was related to *increased* deactivation, indicating that deactivation is not always cognitively advantageous. Whether this is a task-specific effect requires further investigation.

The behavioural performance of the two patient groups, relative to the control group, requires consideration. We found that *both* patient groups, irrespective of lifetime affective morbidity, performed less well at the 0 dot-back task condition compared with controls. We strongly suspect this is due to disease burden and the uncontrolled effects of antiepileptic medication on the attention networks. In the 1 dot-back condition, the PHx group performed more poorly than both control groups; whereas in the 2 dot-back condition, both TLE groups exhibited equal performance level. Collectively, these findings are suggestive of a 'weighted' interaction between psychopathology and TLE. Consistent with this hypothesis, previous research has reported that TLE patients per se are poorer on the 2 dot-back condition.[@R53]

Our findings also challenge the 'default-mode interference hypothesis',[@R83] which proposes that in a normal functioning system, the task-negative (DMN) components will be reduced during the transition from rest to goal-directed action, which is anticorrelated with activation in the task-positive network. Episodic attentional lapses and deficits in performance are considered to be associated with *intruding* DMN activity during task-specific processing. The performance impairments in the PHx group in this study cannot be explained by reduced deactivation of the DMN activity. Although the default mode interference hypothesis does not involve an inverted U-shape aspect as yet,[@R83] it may be that reduced deactivation of the DMN may preclude adequate task positive activation or, alternatively, increased deactivation may paradoxically result in hypervigilance to irrelevant aspects of the task thereby causing distractions. The investigation of these possible explanations requires further research. Although the majority of functional magnetic resonance imaging (fMRI) studies in primary affective disorders focus on emotional processing,[@R84] there is some evidence that psychiatric medication has a modulating effect on cognitive processing (see[@R85] for review). We explored medication effects by removing patients from the analysis who were currently taking antidepressant/anxiolytic medication (n=5). Despite the loss of statistical power, we replicated our principal finding that the PHx group significantly deactivated the same cluster (sACC) more than the HV and nPHx groups.

Studies reporting increased task-related DMN activation have been informed by patients with a current affective diagnosis.[@R44] [@R57] Our inclusion of current mood state (BDI-FS and BAI) as covariates in our primary analysis and the removal of PHx patients with moderate to severe symptoms in post hoc analyses indicate that the variance in the negative BOLD signal (deactivation) in the sACC for the PHx group was independent of current mood state or severity. We interpret this finding as evidence of an enduring trait rather than state-like abnormality in TLE patients with a lifetime history of affective psychopathology.

There are several methodological strengths of our study that further support our primary finding. This study employed a clinical diagnosis of lifetime affective disorders. No single method is optimal to assess psychiatric functioning in TLE,[@R14] but the merit of a psychiatric evaluation is that it not only considers transient mood states as reflected by self-report indices, but the full context of psychopathology, including medication-related and peri-ictal symptoms.[@R16] Furthermore, as all patients were assessed by a neuropsychiatrist investigating the prevalence of lifetime and current psychiatric morbidity, we feel confident that our TLE-only group had no cases of undiagnosed psychopathology which is often overlooked in neurological consultations.[@R86]

We employed a cognitive fMRI paradigm that produces robust progressive deactivations in relation to increasing task demands in HV and TLE patients.[@R53] Moreover, we did not generate a subtraction contrast at the individual level. Instead, we used progressive deactivation contrasts at a second-level analysis, increasing the confidence that our main effect is driven by increased progressive deactivation as cognitive load increases, rather than a lack of activation between rest and task.[@R40]

We also performed correlational analyses to evaluate whether differences in task performance were related to sACC deactivation in the PHx group. No significant relationship or trend was observed for any condition, suggesting that sACC deactivation is pathological and related to lifetime affective psychiatric morbidity.

Our study does not address the issue of causality. The lack of significant difference in deactivation of the sACC between those with current and previous affective diagnoses and the TLE group without a psychiatric history most likely reflects the small sizes of the subgroups. Further studies with larger groups are needed to clarify this matter.

Several limitations of this study should be noted. We did not include individuals with primary affective disorders as a comparison group, which does limit the interpretation of the findings. However, we were principally interested in the effect of depression/anxiety in the *context* of TLE on DMN function, based on consistent evidence for reduced DMN deactivation in primary affective disorders.[@R40] [@R41] [@R43] Our TLE groups were heterogeneous although divergent MRI abnormalities were evenly distributed across the groups. We have not accounted for the influence of AEDs on the DMN and/or WM function.[@R87] The majority of our patients were taking AED polytherapy in a variety of combinations. There were no significant differences in the number of AEDs between patient groups. This serves to limit the generalisability of the current study to pharmaco-resistant TLE patients. In addition, our fMRI results failed to achieve significance with correction for multiple comparisons. However, the cluster extent was \>20 voxels, reducing the likelihood of false positives.[@R88]

The present study is the first to address DMN-related deactivation in TLE patients with a lifetime diagnosis of affective psychopathology. We observed significant deactivation of an 'affective network' node (sACC) in patients with a lifetime affective diagnosis with increasing task demands that conferred no cognitive benefit. Post hoc imaging analyses indicated that this finding was not associated with structural differences in the sACC. Our findings suggest the combination of an affective disorder and TLE has a unique pathophysiological basis supporting the growing body of research indicating that affective psychopathology in TLE has a neurobiological correlate[@R89] and, in this context, the DMN performs differently compared with network activity in primary affective disorders (reduced deactivation).[@R40] Prospective serial neuroimaging studies are needed to unravel the causal mechanisms underlying task-related DMN functional alterations and affective psychopathology in TLE.
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